Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World Experience
{{output}}
Introduction: The optimal venetoclax-based treatment for patients with relapsed/refractory (R/R) CLL is still unknown, especially for high-risk patients. Methods:... ...